Latest1 information on COVID-19
©2022 Stanford Medicine
Not Recruiting
Trial ID: NCT03014700
Repurposing of Fibrinogen Concentrate as a Cost-Effective and Safe Hemostatic Agent in Infants Undergoing Cardiac Surgery on Cardiopulmonary Bypass
Inclusion Criteria:
- Neonates of at least 32 weeks of gestational age and infants up to 12 months of age
with the diagnosis of congenital heart disease, requiring open heart surgery with
cardiopulmonary bypass
Exclusion Criteria:
- Pre-existing coagulopathy, including unexplained bleeding or history of clotting
biological: Fibrinogen Concentrate
biological: Cryoprecipitate
Not Recruiting
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Glyn D Williams, MBChB, FFA
650-723-5728